FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Bristol-Myers Pays $75m Over Medicaid Rebates Case

Bristol-Myers Squibb agrees to pay the U.S. Government and participating states a total of $75 million to resolve allegations that it knowingly underp...

Federal Register

FDA Revokes EUA for Respirator Decontaminator

Federal Register notice: FDA announces an Emergency Use Authorization revocation of NovaSterilis Nova2200 using the NovaClean decontamination process....

Medical Devices

Empirical Spine Breakthrough for Spinal Tension Band

FDA grants Empirical Spine a breakthrough device designation for its LimiFlex Paraspinous Tension Band and its use in spinal surgery.

Federal Register

Drug Registration 2016 Rule Corrected

Federal Register notice: FDA corrects an 8/31/2016 amended final rule that listed inaccurate cross-references to FDAs drug establishment registration ...

Federal Register

Review Period Set for Biomimics Vascular Stent

Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Veryan Medicals Biomimics 3D Vascular Stent Sys...

Special Counsel Troubled by FDA Response to Whistleblower

Special Counsel Henry Kerner says he is troubled by the way FDA handled a whistleblower complaint involving inspections at biologic facilities.

Medical Devices

Accelerate Sustainable Capability Pilot Volunteers Sought

FDA provides information for applying to participate in the Medical Device Innovation Consortium Accelerate Sustainable Capability pilot study.

Federal Register

Review Period Set for Tpoxx Smallpox Drug

Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Siga Technologies Tpoxx (tecovirimat monohydrat...

Federal Register

Cutivate Not Withdrawn Due to Safety/Efficacy: FDA

Federal Register notice: FDA determines that Fougera Pharmaceuticals Cutivate (fluticasone propionate) ointment, 0.005%, was not withdrawn from sale f...

Federal Register

Novartis Serentil Not Withdrawn Due to Safety/Efficacy

Federal Register notice: FDA determines that Novartis Serentil (mesoridazine besylate) tablets 10 mg, 25 mg, 50 mg, and 100 mg were not withdrawn from...